Sign in

CIK 0001626971 · Non-accelerated filer<br>Smaller reporting company

Corvus Pharmaceuticals, Inc.

Sign in to watch
Ticker
CRVS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464670809
Phone
(650) 900-4520
Business address
901 GATEWAY BLVD, THIRD FLOOR, SOUTH SAN FRANCISCO, CA, 94080
  1. 8-K Event Material agreement
  2. 424B4 Offering Prospectus
  3. CT ORDER Other Confidential Order
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Open-market buy 10% owner bought 20,000 shares at $10.95 ($219,000)
  7. 4 Open-market buy President and CEO bought 25,000 shares at an average $9.88 ($247,084)
  8. EFFECT Other Notice of Effectiveness
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 8-K Event Shareholder vote results
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. 8-K Event Regulation FD disclosure · Other events
  18. S-3/A Offering Registration Statement
  19. SC 13G/A Stake Amended Statement of Ownership
  20. 10-Q Report Quarterly Report

Page 24 of 30 · 584 filings